Fertility Test Market – Global Leaders & Growth Strategies Adopted by Them

The global fertility test market is projected to reach USD 583.1 million by 2023 from USD 411.8 million in 2018, at a CAGR of 7.2%.

Key Questions Addressed by the Report:

What are the growth opportunities related to the adoption of fertility test products across major regions in the future?
Emerging countries have immense opportunities for the growth and adoption of ovulation prediction kits. Will this scenario continue in the next five years?
Where will all the advancements in products offered by various companies take the industry in the mid- to long-term?
How will the increasing use of ovulation tracking mobile apps and fertility-tracking websites affect the growth of the market?

Growth in the fertility test market can be attributed to factors such as the increasing first-time pregnancy age in women, declining fertility rate among men and women, growing number of women suffering from disorders such as PCOS, emergence of advanced ovulation monitors, and increased awareness of fertility testing in both developed as well as developing countries.

Download PDF Brochure@

On the other hand, the unproven accuracy of urine-based ovulation monitors in women suffering from PCOS and the lesser precision to confirm ovulation using ovulation prediction kits are the factors that are expected to restrain market growth to a certain extent during the forecast year.

Analysis of the market developments between 2015 and 2018 revealed that several growth strategies such as product launches, enhancements, and strategic acquisitions were adopted by the market players to strengthen their product portfolios and maintain a competitive position in the fertility test market. Among these business strategies, product launches was the most widely adopted growth strategies by the players in the fertility test market.

Recent Developments:

In 2017, Swiss Precision Diagnostics (Switzerland) launched its Clearblue Connected Ovulation Test System.

In 2017, NFI Consumer Healthcare (US) a division of Gregory Pharmaceutical Holdings (US) completed the acquisition of e.p.t over-the-counter pregnancy test kit brand from Prestige Brands Holdings.

In 2017, Fairhaven Health (US), launched TempCue, a basal body temperature (BBT) thermometer.

In 2016, Fertility Focus (UK) launched OvuSense App.

Swiss Precision Diagnostics (Switzerland)
 held the leading position in the global fertility test market in 2017. The company is one of the leading manufacturers and suppliers of fertility/ovulation tests for women. Clearblue is the flagship product of the company and has a very strong brand presence in countries such as the US, the UK, and Europe. 

Along with this, the company’s wide distribution network and innovative marketing strategies are the key factors contributing to its dominant share in the market. With the aim to maintain its dominant share in this highly competitive market, SPD focuses on product launches as its key growth strategy.

Church & Dwight (US)
 held the second position in the global fertility test market, in 2017. The company has a strong geographic presence with subsidiaries across seven countries including the UK, France, Germany, Canada, Mexico, Australia, and Brazil. Church & Dwight provides its fertility testing products to a large customer base through its wide distribution across 130 countries. 

The company is focusing its efforts to increase awareness about issues related to infertility and help women understand their reproductive health and fertile window to improve conception rate. Church & Dwight is expected to witness growth in the coming years due to its multiple initiatives to create awareness regarding fertility.

Request Sample Pages@

North America is expected to dominate the fertility test market during the forecast period.

Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to account for the largest share of the global fertility test market during the forecast period (2018-2023).

The large share can be attributed to the growing use of fertility monitoring devices for contraception and rising awareness about the benefits of ovulation monitors through social media, marketing campaigns, and e-commerce sites. In addition, the emergence of advanced easy-to-use fertility monitors with high accuracy is one of the key factors propelling the growth of the fertility test market in North America.